A global pharmaceutical producer was experiencing technological and operational complexities in managing an enterprise small molecule combinatorial library, which made selecting new drug leads slow and prohibitively expensive. With the help of BIOVIA Pipeline Pilot, the company was able to automate screening of compound libraries for candidate selection, resulting in:
- Automated and enhanced input processes for determining chemical compounds
- Increased compound library by 55% while reducing overall operating costs by over 50%
- Efficient and effective access to chemical compound screening
Download the case study, “Streamlining Small Molecule R&D with BIOVIA Pipeline Pilot” to learn more.